References in periodicals archive ?
Also an increase in the blood flow leads to further increase in the portal hypertension.
Portal hypertension is the most common and lethal complication of chronic liver disease.
Statin use also was associated with a 27% lower risk of variceal bleeding or progression of portal hypertension, based on an analysis of 110 events in 236 patients from three trials (RR, 0.
Liver cirrhosis is characterized by extensive fibrosis not only involving hepatic parenchyma but also the portal tract leading to the well-known complication of portal hypertension (1).
Portal hypertension is the pathophysiological basis for the development of hepatic hydrothorax.
All the causes of UGIB were associated with alcohol consumption, and smoking was most commonly related to portal hypertension (n=11) followed by gastritis (n=2) and peptic ulcer (n=2).
The aetiology in that study was hepatitis B virus (HBV), HCV, non-B non-C cirrhosis, alcoholic liver disease, non-cirrhotic portal hypertension and Wilson's disease compared to HCV alone in our study.
The diagnostic criteria for HPS are: "Partial oxygen pressure < 80 mmHg or oxygen alveolar-arterial gradient [greater than or equal to] 15 mmHg while breathing room air, positive findings in the contrast, portal hypertension (more common) with or without cirrhosis.
KEY WORDS: Doppler waveform, Octreotide, Hepatic vein, Portal hypertension.
Portal hypertension is a frequent and dreadful complication of chronic liver disease and its presence is a hard endpoint for clinically relevant outcomes in terms of varices, ascites, hepatorenal syndrome and encephalopathy [1, 2].
Global Markets Direct's, 'Portal Hypertension - Pipeline Review, H1 2016', provides an overview of the Portal Hypertension pipeline landscape.
Therefore, SVT leads to the increase in splenic outflow via the short gastric and gastroepiploic veins, known as left-sided or sinistral portal hypertension.
PAH may be primary or idiopathic, or associated with other diseases including HIV infection, connective tissue disease, portal hypertension, and congenital heart disease.
Khan's interest include Hepatitis C and B, Cirrhosis of the liver, portal hypertension, liver cancer, peticulcer disease, colitis, GI Maligancies and pancreatobility disease etc.
In patients with portal hypertension, the most common site of varices is at the esophageal level.